Atlas Trials

A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Clinical trial NCT02223884 · COMPLETED

Trial details

NCT number
NCT02223884
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2011-07-01
Primary completion
2014-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.